Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

Grünenthal buys into Kyowa Kirin’s mature medicines portfolio

Canadian HCPs given digital era empowerment recommendations

EU launches AI-powered real-world data project for cancer therapies

mRNA can deliver universal flu vaccine, say US researchers

amivantamab

Janssen J&J Johnson and Johnson pharmaceutical companies

News/ News/ Oncology

J&J files lung cancer bispecific amivantamab for FDA approval

Phil Taylor amivantamab, AstraZeneca, Janssen, Johnson & Johnson, Non-small cell lung cancer, Tagrisso 0 Comment

Johnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big

X

J&J files lung cancer bispecific amivantamab for FDA approval

https://pharmaphorum.com/news/jj-files-lung-cancer-bispecific-amivantamab-for-fda-approval/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

J&J builds case for antidepressant Spravato with head-to-head trial
FDA rejects Spectrum's lung cancer drug poziotinib
Opdivo backed by NICE for rare gastro-oesophageal cancers
EU launches AI-powered real-world data project for cancer therapies
Pharma M&A rumour mill grinds out Mirati's name again

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com